$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the longest resistance period to serputinib/serpatinib?
2026-02-01 22:25:32
Check Details
A full introduction to Enasidenib (ensidipine), learn about this new drug!
2026-02-01 22:25:32
Check Details
What is the recommended dose of avatrombopag tablets/sucoxin at one time?
2026-02-01 22:25:32
Check Details
Should people with pulmonary fibrosis take nintedanib for life? Do I need to take this drug for life?
2026-02-01 22:25:32
Check Details
What possible interactions does bimetinib have with other medications? What should I pay attention to?
2026-02-01 22:25:32
Check Details
Is teritolumab a targeted drug? How is it different from traditional medicine?
2026-02-01 22:25:32
Check Details
What should I pay attention to when taking Quizartinib? What are the common precautions when using it?
2026-02-01 22:25:32
Check Details
What is the mechanism of action of Tucatinib? How to target HER2-positive cancers?
2026-02-01 22:25:32
Check Details
Is Apelvis included in medical insurance? Medical insurance payment scope and patient reimbursement process
2026-02-01 22:25:32
Check Details
Which first-line drug does selumetinib belong to? Positioning and applicable stages in the treatment plan
2026-02-01 22:25:32
Check Details
Is cabozantinib effective in patients with advanced lung cancer? Use cycle and life span extension
2026-02-01 22:25:32
Check Details
What is the medical insurance reimbursement price of bedaquiline? How can patients reimburse part of the expenses through medical insurance?
2026-02-01 22:25:32
Check Details
1
2
...
1449
1450
1451
1452
1453
1454
1455
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
2
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
3
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
4
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
5
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
6
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
7
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
8
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
9
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
10
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
11
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
12
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis